We found that effective siRNA-mediated knockdown of LINC00992 (Supplemental Figure 3, A–C) inhibited the growth (Supplemental Figure 3, D–F) and impaired the clonogenic capacity of ER+ BC cells (Supplemental Figure 3, G and H). This evidence concerns the gene LINC00992 and breast cancer.